- Home
- PCVX vs NYT Comparison
PCVX vs NYT Comparison
Compare PCVX & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | NYT |
|---|---|---|
| Founded | 2013 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 9.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | NYT |
|---|---|---|
| Price | $44.46 | $67.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $101.67 | $63.83 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.06% |
| EPS Growth | N/A | ★ 21.46 |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $2,722,033,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $6.86 |
| P/E Ratio | ★ N/A | $33.13 |
| Revenue Growth | N/A | ★ 8.49 |
| 52 Week Low | $27.66 | $44.83 |
| 52 Week High | $93.77 | $68.48 |
Technical Indicators
Market Signals| Indicator | PCVX | NYT |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 73.07 |
| Support Level | $42.55 | $63.98 |
| Resistance Level | $45.15 | $68.54 |
| Average True Range (ATR) | 1.95 | 1.09 |
| MACD | -0.65 | 0.16 |
| Stochastic Oscillator | 24.74 | 87.50 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.